Brain-derived neurotrophic factor protects dopaminergic cells from 6-hydroxydopamine toxicity.
Spina
M B
MB
Regeneron Pharmaceuticals, Tarrytown, New York 10591.
Hyman
C
C
Squinto
S
S
Lindsay
R M
RM
D015655:1-Methyl-4-phenylpyridinium / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D019208:Brain-Derived Neurotrophic Factor; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004298:Dopamine / Q000378:metabolism; D005978:Glutathione / Q000031:analogs & derivatives / Q000378:metabolism; D019803:Glutathione Disulfide; D005980:Glutathione Reductase / Q000378:metabolism; D007700:Kinetics; D008636:Mesencephalon / Q000166:cytology / Q000201:enzymology; D009414:Nerve Growth Factors / Q000494:pharmacology*; D009419:Nerve Tissue Proteins / Q000494:pharmacology*; D009474:Neurons / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D009498:Neurotoxins / Q000494:pharmacology*; D016627:Oxidopamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D019208:Brain-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D009498:Neurotoxins; D016627:Oxidopamine; D005980:Glutathione Reductase; D005978:Glutathione; D015655:1-Methyl-4-phenylpyridinium; D019803:Glutathione Disulfide; D004298:Dopamine